Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Novartis (China) | Researchclopedia

Back to institutions

Novartis (China)

Beijingcompany

2,343

Works

239,410

Citations

222

h-index

Top Research Topics

Computational Drug Discovery Methods Psoriasis: Treatment and Pathogenesis Epigenetics and DNA Methylation

Top Researchers

Xiaohong Chen Chongqing University

19,059 works495,225 citationsh-index: 258

Recent Research

Green Chemistry Articles of Interest to the Pharmaceutical Industry

Miles H. Aukland,Theresa Dutschei,et al.

20260 citations

Monoclonal and Polyclonal Antibodies Research

Asthma and respiratory diseases

Health Systems, Economic Evaluations, Quality of Life

Cancer-related gene regulation

CAR-T cell therapy research

Dermatology and Skin Diseases

Autoimmune Bullous Skin Diseases

Urticaria and Related Conditions

Chemical Synthesis and Analysis

Victoria Delgado Universidade Federal de Ouro Preto

1,447 works265,899 citationsh-index: 134

Jeroen J. Bax Leiden University

3,096 works244,399 citationsh-index: 189

Edward L. Giovannucci Harvard University

2,686 works189,208 citationsh-index: 200

Hugo A. Katus Heidelberg University

2,128 works171,342 citationsh-index: 143

Børge G. Nordestgaard University of Copenhagen

1,752 works164,910 citationsh-index: 192

Final clinical data of a phase 1 dose‐escalation study of WVT078, a BCMA×CD3 bispecific antibody, alone and in combination with γ‐secretase inhibitor WHG626 in patients with relapsed and/or refractory multiple myeloma

Fredrik Schjesvold,Andrew Spencer,et al.

20260 citations

Diagnosing idiosyncratic drug-induced liver injury: lessons from monocyte-derived hepatocyte-like cells

Maria Fernanda Vargas,Stuart Astbury,et al.

20260 citations

WCN26-6819 LONG-TERM STABILIZATION OF KIDNEY FUNCTION REGARDLESS OF BASELINE eGFR AND UPCR IN PATIENTS WITH IgA NEPHROPATHY: SUBGROUP ANALYSES FROM THE ZIGAKIBART PHASE I/II TRIAL

Jonathan Barratt,Eun Young Lee,et al.

20260 citations

Efficacy and safety of secukinumab in patients with active psoriatic arthritis at Week 16 and up to 52 weeks: Results from a Phase III, randomized, double-blind, placebo-controlled bridging study in China

Xiaomei Leng,Yi Liu,et al.

20260 citations

Early exposure-response modeling of an interferon-beta monoclonal antibody (dazukibart) in adults with dermatomyositis

John P. Prybylski,Jing ‘Daisy’ Zhu,et al.

20260 citations